NSD2 Targeting Reverses Plasticity and Drug Resistance in Prostate Cancer

By
Noshin Noorjahan
-
0
162
The authors showed that plasticity-associated treatment resistance in CRPC can be reversed through the inhibition of NSD2, a histone methyltransferase.
[Nature]
Full Article